Revvity | Spese Operative



Operating Expenses Cambiamento Data
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Agilent USD 1.31B 12M 2025-01
Align Technology USD 851.07M 35.5M 2024-12
Bio Techne USD 249.61M 141K 2024-12
Bio-Rad Laboratories USD 609.1M 23.84M 2024-12
Bruker USD 915.5M 119.2M 2024-12
Celltrion KRW 674.25B 128.01B 2024-09
Charles River Laboratories USD 1.17B 277.88M 2024-12
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Danaher USD 5.11B 273M 2024-12
Dentsply International USD 1.41B 1000K 2024-12
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Ecofibre AUD 12.31M 44.07M 2024-06
Edwards Lifesciences USD 1.07B 69.4M 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
Hologic USD 792M 34M 2024-12
Illumina USD 929M 590M 2024-12
Intuitive Surgical USD 1.68B 882M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Laboratory Of America USD 3.11B 85M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Mettler Toledo International USD 730.58M 884.93M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Patterson Companies USD 1.53B 109.77M 2025-01
Pharma Mar EUR 43.47M 3.3M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Quest Diagnostics USD 2.26B 125M 2024-12
Quidel USD 808.2M 96.1M 2024-12
Repligen USD 162.7M 10.11M 2024-09
Revvity USD 610.62M 24.72M 2024-12
Sartorius EUR 725.4M 29M 2024-09
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Waters USD 580.45M 51.28M 2024-12
Zz Pientze Pharmaceu 1.67B 86.7M 2024-09



Revvity Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.